S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
NASDAQ:CLNN

Clene News Headlines

$3.00
-0.01 (-0.33%)
(As of 01/14/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.71
$3.08
50-Day Range
$3.00
$6.03
52-Week Range
$2.71
$17.82
Volume
375,741 shs
Average Volume
186,441 shs
Market Capitalization
$186.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.08
Get Clene News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLNN and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Clene Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CLNN
News Sentiment

-0.09

0.31

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CLNN Articles
This Week

3

6

CLNN Articles
Average Week



Clene (NASDAQ:CLNN) News Headlines Today

SourceHeadline
nasdaq.com logoClene Inc Shares Close in on 52-Week Low - Market Mover - Nasdaq
nasdaq.com - January 15 at 10:07 AM
nasdaq.com logoClene Inc Shares Close the Day 15.2% Lower - Daily Wrap - Nasdaq
nasdaq.com - January 14 at 5:28 PM
nasdaq.com logoClene Inc Shares Fall 0.3% Below Previous 52-Week Low - Market Mover
nasdaq.com - January 13 at 2:59 AM
nasdaq.com logoClene Inc. Rings the Nasdaq Stock Market Closing Bell in Celebration of its 1st Listing Anniversary
nasdaq.com - January 4 at 7:19 PM
nasdaq.com logoClene Inc. Rings the Closing Bell in Celebration of its 1st Listing Anniversary
nasdaq.com - January 4 at 7:19 PM
globenewswire.com logoClene Nanomedicine's Patent Portfolio Grows to More Than - GlobeNewswire
globenewswire.com - December 15 at 8:24 AM
globenewswire.com logoClene Nanomedicine's Facility Improvement Project Receives $1 Million Grant Award from the Maryland Department of Housing and Community Development (DHCD) - GlobeNewswire
globenewswire.com - December 13 at 10:50 PM
seekingalpha.com logoClene jumps 10%, subsidiary receives $1M grant from the Maryland Department of Housing and Community Development - Seeking Alpha
seekingalpha.com - December 13 at 12:49 PM
finance.yahoo.com logoInsider Buying: The Clene Inc. (NASDAQ:CLNN) Independent Chairman of the Board Just Bought 3.8% More Shares
finance.yahoo.com - December 12 at 10:23 AM
benzinga.com logoClene Reports Its Nanomedicine Segment To Present RESCUE-ALS Phase 2 Data In Late-Breaking Session At Int'l. Symposium On Amyotrophic Lateral Sclerosis Dec. 10 At 1:05 p.m. EST - Benzinga
benzinga.com - December 10 at 10:09 AM
finance.yahoo.com logoClene Nanomedicine to Present RESCUE-ALS Phase 2 Data in Late-Breaking Session at 32nd International Symposium on ALS/MND - Yahoo Finance
finance.yahoo.com - December 10 at 10:09 AM
finance.yahoo.com logoClene Nanomedicine’s RESCUE-ALS Phase 2 Results Selected for Late-Breaking Presentation at 32nd International Symposium on ALS/MND - Yahoo Finance
finance.yahoo.com - December 7 at 8:40 AM
nasdaq.com logoClene Inc. (CLNN) Upgraded to Buy: What Does It Mean for the Stock? - Nasdaq
nasdaq.com - December 2 at 8:19 PM
nasdaq.com logoWall Street Analysts Believe Clene Inc. (CLNN) Could Rally 288%: Here's is How to Trade - Nasdaq
nasdaq.com - December 2 at 3:15 PM
globenewswire.com logoClene Nanomedicine Presents Updated Data from RESCUE-ALS - GlobeNewswire
globenewswire.com - December 1 at 9:23 AM
markets.businessinsider.com logoDoes Clene Inc. (CLNN) Have the Potential to Rally 238% as Wall Street Analysts Expect?
markets.businessinsider.com - November 30 at 12:12 AM
nasdaq.com logoDoes Clene Inc. (CLNN) Have the Potential to Rally 238% as Wall Street Analysts Expect? - Nasdaq
nasdaq.com - November 16 at 1:59 PM
benzinga.com logoClene Reports Completion Of Patient Enrollment In HEALEY Amyotrophic Lateral Sclerosis Platform Trial - Benzinga
benzinga.com - November 15 at 9:09 AM
globenewswire.com logoClene Announces Completion of Patient Enrollment in the HEALEY ALS Platform Trial - GlobeNewswire
globenewswire.com - November 15 at 9:09 AM
finance.yahoo.com logoClene Announces Completion of Patient Enrollment in the HEALEY ALS Platform Trial
finance.yahoo.com - November 15 at 9:09 AM
au.finance.yahoo.com logoClene Reports Third Quarter 2021 Operating and Financial Highlights
au.finance.yahoo.com - November 10 at 10:56 PM
nasdaq.com logoClene Inc. (NASDAQ:CLNN) is up 13%, but insiders still continue to see a loss of US$872k on their US$2.0m investment - Nasdaq
nasdaq.com - November 10 at 12:55 PM
finance.yahoo.com logoClene Reports Third Quarter 2021 Operating and Financial Highlights - Yahoo Finance
finance.yahoo.com - November 9 at 10:36 AM
streetinsider.com logoClene (CLNN) Reports Top-Line Results from Phase 2 RESCUE-ALS - StreetInsider.com
streetinsider.com - November 4 at 10:21 AM
nasdaq.com logoHealth Care Sector Update for 11/02/2021: RCM,ENDP,CLNN,NBIX,TEVA,JNJ,ABBV - Nasdaq
nasdaq.com - November 2 at 6:03 PM
benzinga.com logoClene Reports Its RESCUE-ALS Phase 2 Trial Did Not Meet Primary, Secondary Endpoints - Benzinga
benzinga.com - November 2 at 8:01 AM
finance.yahoo.com logoClene Nanomedicine Announces Top-Line Results from Phase 2 RESCUE-ALS Clinical Trial - Yahoo Finance
finance.yahoo.com - November 2 at 8:01 AM
finance.yahoo.com logoClene Nanomedicine Announces Top-Line Results from Phase 2 RESCUE-ALS Clinical Trial
finance.yahoo.com - November 2 at 8:01 AM
finance.yahoo.com logoClene Nanomedicine Presents Blinded Interim Update from VISIONARY-MS and Positive Results from REPAIR-MS Phase 2 Clinical Trials - Yahoo Finance
finance.yahoo.com - October 16 at 9:15 AM
globenewswire.com logoClene Nanomedicine Presents Blinded Interim Update from - GlobeNewswire
globenewswire.com - October 14 at 10:24 AM
finance.yahoo.com logoClene Nanomedicine Presents Blinded Interim Update from VISIONARY-MS and Positive Results from REPAIR-MS Phase 2 Clinical Trials
finance.yahoo.com - October 14 at 10:24 AM
finance.yahoo.com logo44 Biggest Movers From Yesterday - Yahoo Finance
finance.yahoo.com - October 5 at 12:45 PM
nasdaq.com logo3 Stocks That Could Double From Current Levels; Oppenheimer Says ‘Buy’ - Nasdaq
nasdaq.com - October 4 at 6:43 AM
globenewswire.com logoClene Announces Initiation of a Second FDA Expanded Access - GlobeNewswire
globenewswire.com - September 23 at 1:37 PM
finance.yahoo.com logoClene Announces Initiation of a Second FDA Expanded Access Program with CNM-Au8 for People Living with Amyotrophic Lateral Sclerosis - Yahoo Finance
finance.yahoo.com - September 23 at 8:36 AM
nasdaq.com logoHow Much Of Clene Inc. (NASDAQ:CLNN) Do Insiders Own? - Nasdaq
nasdaq.com - September 20 at 7:42 AM
benzinga.com logoClene Presents Phase 2 CNM-Au8 CNS Target Engagement Data at the International Parkinson and Movement Dis - Benzinga
benzinga.com - September 18 at 1:53 PM
globenewswire.com logoClene Presents Phase 2 CNM-Au8 CNS Target Engagement Data - GlobeNewswire
globenewswire.com - September 18 at 1:53 PM
finance.yahoo.com logoClene Presents Phase 2 CNM-Au8 CNS Target Engagement Data at the International Parkinson and Movement Disorder Society Virtual Congress 2021 - Yahoo Finance
finance.yahoo.com - September 17 at 10:01 AM
streetinsider.com logoForm 8-K Clene Inc. For: Sep 09 - StreetInsider.com
streetinsider.com - September 9 at 5:11 PM
finance.yahoo.com logoClene Completes Final Patient Visit in Phase 2 RESCUE-ALS Study: Topline Data Readout Expected Q4 2021 - Yahoo Finance
finance.yahoo.com - September 9 at 8:51 AM
finance.yahoo.com logoWhat Percentage Of Clene Inc. (NASDAQ:CLNN) Shares Do Insiders Own? - Yahoo Finance
finance.yahoo.com - September 7 at 11:52 AM
finance.yahoo.com logoWhat Percentage Of Clene Inc. (NASDAQ:CLNN) Shares Do Insiders Own?
finance.yahoo.com - September 7 at 11:52 AM
finance.yahoo.com logoClene Nanomedicine to Present at Upcoming Virtual Investor Conferences - Yahoo Finance
finance.yahoo.com - September 2 at 11:11 AM
globenewswire.com logoClene Nanomedicine to Present at Upcoming Virtual Investor - GlobeNewswire
globenewswire.com - August 31 at 9:27 AM
barrons.com logoClene Inc.
barrons.com - August 22 at 7:55 AM
nasdaq.com logoClene Inc Shares Close the Day 12.6% Lower - Daily Wrap - Nasdaq
nasdaq.com - August 18 at 5:15 PM
bizjournals.com logoClene Nanomedicine to quadruple manufacturing capacity across two sites in Cecil County - Baltimore Business Journal - Baltimore Business Journal
bizjournals.com - August 12 at 3:20 PM
streetinsider.com logoForm 8-K Clene Inc. For: Aug 10 - StreetInsider.com
streetinsider.com - August 11 at 8:51 AM
globenewswire.com logoClene Enters into Two Leases to Materially Expand Manufacturing Capacity of its Lead Asset CNM-Au8 - GlobeNewswire
globenewswire.com - August 11 at 8:51 AM
Get Clene News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLNN and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.